Take the next step in your #hepatology career.
Become an AASLD Fellow or Associate Fellow and join a distinguished community recognized for professional achievement and leadership in the field.
Apply by Dec. 15: www.aasld.org/fellows-program

Breaking: Semaglutide (Wegovy) becomes the first GLP-1 receptor agonist approved to treat metabolic dysfunction-associated steatohepatitis (MASH) with moderate-to-a… #Drugapproval #Fibrosis #GLP1agonists #Hepatology #Liverdisease #Drugapproval #Fibrosis #GLP1agonists #Hepatology #Liverdisease …
Take the next step in your #hepatology career.
Become an AASLD Fellow or Associate Fellow and join a distinguished community recognized for professional achievement and leadership in the field.
Apply by Dec. 15: www.aasld.org/fellows-program
📢 New Issue in #LiversMDPI
📚 Volume 6, Issue 4 is now online with 27 articles
⭐ Cover Story: Hepatic crown-like structures, cell heterogeneity, and their role in steatotic liver diseases
🔗 Full issue here: mdpi.com/2673-4389/6/4
A new study in the Canadian Liver Journal (9.3) examines the effects of a home pedometer-monitored program on frailty, clinical status, and long-term walking levels in cirrhotic patients. Read the article: bit.ly/CanLiJ9-3d @uchicagomedicine.bsky.social #Hepatology
📢Only one day left for #LiversMDPI Webinar | Biomarkers in Drug-Induced Liver Injury
📅16 Sept 2026 |
⏰3 pm CEST | 9 am EDT
🔗Final Day - Free Registration: brnw.ch/21x5uSr
📖 More Information at: brnw.ch/21x5uPe
Immune metabolic reprogramming in MASLD
#MASLD #LiverSky #Hepatology
https://doi.org/https://www.sciencedirect.com/science/article/pii/S2589555926002983?dgcid=rss_sd_all
⏰ One month left to submit a Letter of Intent!
The $500,000 #StravitzVisionaryAward supports early- to mid-career investigators pursuing bold, high-impact research that could shape the future of #hepatology.
Deadline: Oct. 12
Learn more: https://bit.ly/4wRT23e
While vascular control of organ function mechanisms have been discovered in essentially all major organs, the mechanisms of translating milieu factors into angiocrine signalling mechanisms remain largely elusive.
#LiverResearch #LiverSky #Hepatology
https://doi.org/10.1038/s41467-026-76966-7
📢 Call for Reading | Review in #LiversMDPI
🧬 Palliative care in ESLD remains underutilized and faces barriers.
🩺 The review highlights improved symptom control and quality of life.
📖 More: www.mdpi.com/2673-4389/5/...
What could quietly change GI practice next? 👀
A new therapy for SBS-IF.
A biomarker for complicated Crohn’s.
Safer sedation in obesity.
The economics of MASH screening.
The interesting part is in the details.
Read the latest on GastroAGI.
We hope you'll be at the 2026 CASL Single Topic Conference on Steatotic Liver Disease in Montreal, September 18-19. Looking forward to connecting with the Canadian liver health community.
Learn more: caslstc.ca
Perspectum is a Gold Sponsor of the 2026 Frontiers in Gastroenterology: Conference for Nurses and Healthcare Professionals.
See you in Los Angeles!
#Perspectum #LiverMultiScan #Gastroenterology #Hepatology #GINursing #LiverHealth
🧠 In the latest #ESPGHANPodcast, Prof Dr Valérie McLin explores hepatic encephalopathy and the spectrum of neurocognitive dysfunction known as SLiPS in children with chronic liver disease or portosystemic shunting.
🎧 Listen on your preferred platform: t.co/zHK80rkrNt
#ESPGHAN #Hepatology #Podcast
A better way to revise GI: ask the question you actually have.
From hepatitis to HCC, get focused, evidence-led answers with gastroagi.com
Made for GI. Only GI.
Hepatic stellate cells (HSCs) represent an important source of cancer-associated fibroblasts (CAFs) in HCC.
#LiverFibrosis #LiverSky #Hepatology
https://doi.org/10.3389/fimmu.2026.1930718
UBE2N deficiency contributes to MASH development via p62-regulated mitophagy and PANoptosis
#MASH #LiverSky #Hepatology
https://doi.org/10.1038/s42255-026-01590-0
Restoring β-hydroxybutyrate reverses T cell exhaustion and improves antitumor, antiviral, and CAR T cell immunity in aged hosts, revealing a metabolic strategy to rejuvenate immune function during aging.
#LiverResearch #LiverSky #Hepatology
https://doi.org/10.1016/j.cmet.2026.08.009
Breaking: Semaglutide (Wegovy) becomes the first GLP-1 receptor agonist approved to treat metabolic dysfunction-associated steatohepatitis (MASH) with moderate-to-a… #Drugapproval #Fibrosis #GLP1agonists #Hepatology #Liverdisease #Drugapproval #Fibrosis #GLP1agonists #Hepatology #Liverdisease …
Congratulations to Daniela Goyes, MD, MHS, recipient of the Kimberly A. Brown Advanced/Transplant #Hepatology Fellow Award! Join us in celebrating this well-deserved honor.